Condition: NAFLD · Liver Fibroses · Cardiovascular Diseases · Sponsor: University of Roma La Sapienza
Liver fibrosis is the most important prognostic factor in patients with non-alcoholic factor disease. Clinical and biological condition, as diabetes or mutation for PNPLA3, are well known factors associated with liver fibrosis onset and progression. However, little is known about biochemical factors predicting liver fibrosis evolution in large NAFLD populations.
This description comes directly from the study's public registry record.
Francesco Baratta, MD, PI. · +390649972249 · francesco.baratta@uniroma1.it
Daniele Pastori, MD, PI. · +390649972249 · daniele.pastori@uniroma1.it
Always discuss trial participation with your own doctor first.
| Day Service of Internal Medicine and Metabolic Disorders - Policlinico Umberto I - Sapienza University of Rome | Rome, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04036357